New Zealand
Include All CSL Sites

Gardasil® 9


In women aged 9-45yrs, for the prevention of cervical, vulvar, vaginal and anal cancer, precancerous or dysplastic lesions, genital warts and infection caused by Human Papillomavirus (HPV) types 6, 11, 16, 18, 31, 45, 52 and 58. In men aged 9-26yrs for the prevention of anal cancer, precancerous or dysplastic lesions, external genital lesions and infection caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52 and 58.

What is GARDASIL®9?

  • GARDASIL®9 helps protect against the nine most important HPV types that cause a wide range of HPV disease.
  • GARDASIL®9 is given as either 2 doses in those aged 9-14yrs or as 3 doses in those 15yrs and over. High immune responses in studies (much greater than natural infection), and the development of immune memory seem to suggest that no booster dose will be required.
  • The formulation of GARDASIL®9 is based on well-proven technology, which has demonstrated a high level of safety.
  • GARDASIL®9 can be administered by your GP to girls and women aged 9 to 45 years and males aged 9 to 26 years.
  • Routine cervical screening and pap tests are still required for women who have been vaccinated with GARDASIL®9 in order to detect cancers and precancerous lesions caused by HPV types not covered in the vaccine.
  • GARDASIL®9 is FREE for females and males aged 9-26yrs
  • GARDASIL®9 is a prescription medicine and is not funded for people over 26yrs. Therefore a patient charge will apply of approximately $190 per dose (3 doses required) plus any associated doctor’s fees.
  • Ask your Dr or Healthcare Professional if you want to know more about GARDASIL®9.

To view more information visit the HPV vaccine website

Gardasil logo

Note.  Information on this site is not intended to replace the advice given by your doctor or health professional.

From 1 January 2017 Gardasil 9 will be fully funded for both males and females aged 9-26 years. A patient charge will apply for all others outside this age range.

Immunisation does not replace the need for regular cervical cancer screening
GARDASIL 9 is a prescription medicine/vaccine that helps protect against disease caused by the Human Papillomavirus (HPV) types 6, 11, 16, 18, 31, 33, 45, 52 and 58. In females 9 through 45 years of age, it helps prevent: cervical (the lower end of the uterus or womb), vulvar (the outside of the female genitals), vaginal, and anal cancers; abnormal and precancerous (changes in cells which have a risk of turning into cancer) cervical, vaginal, vulvar and anal lesions; genital warts and HPV infection. In males 9-26 years of age, GARDASIL 9 helps prevent anal cancer and precancerous anal lesions; external genital lesions, including genital warts and HPV infection. Each 0.5 mL GARDASIL 9 dose contains the following approximate amounts of L1 protein: 30 mcg of HPV 6; 40 mcg of HPV 11; 60 mcg of HPV 16; 40 mcg of HPV 18; 20 mcg of HPV 31; 20 mcg of HPV 33; 20 mcg of HPV 45; 20 mcg of HPV 52; and 20 mcg of HPV 58. GARDASIL 9 has benefits and risks. Do not use GARDASIL 9 if you or your child have an allergy to GARDASIL or GARDASIL 9 components or have had an allergic reaction after receiving a dose of GARDASIL or GARDASIL 9.Tell your doctor: if you or your child had an allergic reaction to GARDASIL or GARDASIL 9, a bleeding disorder and cannot receive injections in the arm, any illness with a fever higher than 37.8°C, a weakened immune system or taking medicines that affect the immune system; about planned or current pregnancy, recent vaccines or medicines, including those not on prescription. Tell your doctor if you notice any of the following: pain, swelling, redness, itching, bruising, bleeding, and a lump at or around the injection site, headache, fever or high temperature, nausea, dizziness, tiredness, diarrhoea, sore throat, stomach pain, discomfort, skin infection, bleeding or bruising more easily than normal, swollen glands in the neck, armpit or groin, confusion, vomiting, joint pain or painful, swollen joint, aching muscles, unusual tiredness, weakness, chills, generally feeling unwell, very rarely, tingling, numbness or muscle weakness in limbs or fainting. If you notice any of the following, tell your doctor immediately or go to the nearest Accident and Emergency: wheezing; shortness of breath or difficulty breathing; pinkish, itchy swellings on the skin; skin rash; itchiness; swelling of the face, lips, tongue which may cause difficulty in swallowing or breathing; or swelling of other parts of the body. Tell your doctor if you notice any other unwanted effects, or if there is a change in your health that you think might be caused by GARDASIL 9.
Ask your doctor or health care provider if Gardasil 9 is right for you. For further information, consult your doctor or health care provider.
Additional consumer medicine information (dated June 2016) can be obtained from or from Seqirus, Auckland, Freephone 0800 502 757 or GARDASIL®9 is a registered trademark of Merck & Co. Inc., Whitehouse Station, NJ, 08889 USA.

GARD9-037-02/17 TAPS MR5156

For further information, click on the helpful links below.


Helpful Links

Consumer Medicine Information
Medicine Data Sheet

Last Updated: 30-09-2018
© 2019 Seqirus